Sequential FDG-PET predicted patient outcome as early as after the first cycle of neoadjuvant chemotherapy and was more accurate than clinical or histopathologic response criteria including changes in ...
Neoadjuvant chemotherapy is chemotherapy that a person with cancer receives before their primary course of treatment. The aim is to shrink a cancerous tumor using drugs before moving onto other ...
Docetaxel, cisplatin, 5-flourouracil x 3 days (DCF3) compared to docetaxel, cisplatin, 5-flourouracil x 5 days (DCF5) chemotherapy for patients with metastatic or locally advanced, unresectable ...
In a pilot study involving patients with cutaneous squamous-cell carcinoma, a high percentage of patients had a pathological complete response with the use of two doses of neoadjuvant cemiplimab ...
The study compared the adverse events and surgical, pathological, and efficacy outcomes associated with neoadjuvant chemoimmunotherapy vs chemotherapy, particularly focusing on patients with PD-L1 ...
Whether pembrolizumab given both before surgery (neoadjuvant therapy) and after surgery (adjuvant therapy), as compared with pembrolizumab given as adjuvant therapy alone, would increase event-free ...
Neoadjuvant chemotherapy is a course of chemotherapy that’s given before your primary treatment, which is often surgery. Neoadjuvant chemotherapy specifically refers to chemotherapy administered ...
Adjuvant chemotherapy refers to chemotherapy that people receive after another cancer treatment, such as surgery. Neoadjuvant chemotherapy is when a person has chemotherapy as their main treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results